Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gangliosides and cancer].

C Dumontet1, J Portoukalian

  • 1INSERM U 218, centre Léon-Bérard, Lyon, France.

Bulletin Du Cancer
|January 1, 1991
PubMed
Summary

Gangliosides, a type of glycosphingolipid, show altered expression in cancers like melanoma and neuroblastoma. These changes allow gangliosides to serve as tumor markers and targets for immunotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.

BMC pharmacology & toxicology·2020
Same author

Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium.

Blood cancer journal·2020
Same author

Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase.

Bone·2020
Same author

Monoclonal antibody therapy in multiple myeloma.

Leukemia·2017
Same author

Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

The international journal of biochemistry & cell biology·2015
Same author

The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

Biochemical pharmacology·2015

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Context:

  • Gangliosides are glycosphingolipids containing neuraminic acid, found in cell plasma membranes.
  • Their expression varies quantitatively and qualitatively across different cancer types.
  • Altered ganglioside composition impacts tumor cell interactions with their environment.

Purpose:

  • To explore the role of modified ganglioside expression in cancer.
  • To investigate gangliosides as potential tumor markers.
  • To evaluate gangliosides as targets for cancer immunotherapy.

Summary:

  • Cancer cells exhibit altered ganglioside profiles compared to normal cells.
  • Shed gangliosides can modulate host immunity, potentially aiding tumor development.
  • Specific ganglioside modifications in melanoma and neuroblastoma are clinically significant.

Impact:

  • Gangliosides can serve as biomarkers for early cancer detection.
  • Targeting cancer-specific gangliosides offers a promising immunotherapy strategy.
  • Understanding ganglioside alterations deepens insights into tumor biology and host-pathogen interactions.

Related Experiment Videos